These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22591597

  • 1. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
    Li P, Bai X, Sun P, Li D, Lu Z, Cao Y, Fu Y, Bao H, Chen Y, Xie B, Liu Z.
    BMC Vet Res; 2012 May 16; 8():57. PubMed ID: 22591597
    [Abstract] [Full Text] [Related]

  • 2. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013-2018) from Southeast Asia.
    Upadhyaya S, Mahapatra M, Mioulet V, Parida S.
    Viruses; 2021 Sep 21; 13(9):. PubMed ID: 34578467
    [Abstract] [Full Text] [Related]

  • 3. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H, Lian K, Yang F, Jin Y, Zhu Z, Guo J, Cao W, Liu H, He J, Zhang K, Li D, Liu X.
    Vaccine; 2015 Oct 26; 33(43):5772-5778. PubMed ID: 26431990
    [Abstract] [Full Text] [Related]

  • 4. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH, Ko MK, Shin SH, You SH, Jo HE, Jo H, Lee MJ, Kim SM, Lee JS, Kim B, Park JH.
    Vet Microbiol; 2019 Sep 26; 236():108374. PubMed ID: 31500734
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y, Xie B, Liu Z.
    Vet Microbiol; 2014 Jan 31; 168(2-4):294-301. PubMed ID: 24345411
    [Abstract] [Full Text] [Related]

  • 6. [Construction of a full-length infectious cDNA clone of inter-genotypic chimeric foot-and-mouth disease virus].
    Li P, Bai X, Lu Z, Sun P, Qi G, Han C, Liu Z.
    Wei Sheng Wu Xue Bao; 2012 Jan 31; 52(1):114-9. PubMed ID: 22489468
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.
    Li P, Lu Z, Bai X, Li D, Sun P, Bao H, Fu Y, Cao Y, Chen Y, Xie B, Yin H, Liu Z.
    Vet Res; 2014 May 01; 45(1):51. PubMed ID: 24885414
    [Abstract] [Full Text] [Related]

  • 12. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
    Jo HE, Ko MK, Choi JH, Shin SH, Jo H, You SH, Lee MJ, Kim SM, Kim B, Park JH.
    J Vet Sci; 2019 Jul 01; 20(4):e42. PubMed ID: 31364326
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Ko MK, Jo HE, Choi JH, You SH, Shin SH, Jo H, Lee MJ, Kim SM, Kim B, Park JH.
    Vaccine; 2020 Jan 29; 38(5):1120-1128. PubMed ID: 31810782
    [Abstract] [Full Text] [Related]

  • 15. The Pseudoknot Region of the 5' Untranslated Region Is a Determinant of Viral Tropism and Virulence of Foot-and-Mouth Disease Virus.
    Zhu Z, Yang F, Cao W, Liu H, Zhang K, Tian H, Dang W, He J, Guo J, Liu X, Zheng H.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30728251
    [Abstract] [Full Text] [Related]

  • 16. Chimeric vaccine strain of type O foot-and-mouth disease elicits a strong immune response in pigs against ME-SA and SEA topotypes.
    Ko MK, Jo HE, Choi JH, You SH, Shin SH, Jo H, Lee MJ, Kim SM, Kim B, Park JH.
    Vet Microbiol; 2019 Feb 15; 229():124-129. PubMed ID: 30642587
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs.
    Galdo Novo S, Malirat V, Maradei ED, Pedemonte AR, Espinoza AM, Smitsaart E, Lee KN, Park JH, Bergmann IE.
    Vaccine; 2018 Mar 14; 36(12):1570-1576. PubMed ID: 29472132
    [Abstract] [Full Text] [Related]

  • 18. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Mahapatra M, Upadhyaya S, Aviso S, Babu A, Hutchings G, Parida S.
    Vaccine; 2017 Dec 18; 35(51):7147-7153. PubMed ID: 29157957
    [Abstract] [Full Text] [Related]

  • 19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 18; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 20. Sequences outside that of residues 93-102 of 3A protein can contribute to the ability of foot-and-mouth disease virus (FMDV) to replicate in bovine-derived cells.
    Ma X, Li P, Bai X, Sun P, Bao H, Lu Z, Cao Y, Li D, Chen Y, Qiao Z, Liu Z.
    Virus Res; 2014 Oct 13; 191():161-71. PubMed ID: 25116389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.